Monday, March 28, 2016

FDA OKs Xalkori (Crizotinib) for Rare Type of Advanced Lung Cancer

… with advanced, ROS1-positive non-small cell lung cancer. These tumors have a mutation … non-small cell lung cancer. Many people with this type of lung cancer tend to be younger than the average lung cancer patient … people with ROS1-positive non-small cell lung cancer that had spread beyond the …

No comments:

Post a Comment